Simulations Plus, Inc. - Common Stock - Nakit Akışı (NASDAQ:SLP)

Financials

Genel Bakış Tablolar İstatistikler Temettüler

İşletme faaliyetlerinden elde edilen nakit 10.91 M19.2 M17.9 M21.86 M13.32 M18.13 M 24.38 M Yatırım faaliyetlerinden elde edilen nakit -75.51 M-26.74 M4.3 M7.37 M-53.97 M3.56 M -10.23 M Finansman faaliyetlerinden elde edilen nakit 102.37 M-4.68 M-7.62 M-23.27 M-6.57 M-1.15 M 590 K Serbest nakit akışı 8.33 M14.63 M13.93 M18.18 M9.56 M14.78 M 20.81 M

Simulations Plus, Inc. - Common Stock

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.

SLP

Financials

Simulations Plus, Inc. - Common Stock

Haberler

PTC Q2 Earnings & Revenues Beat on AI-Led ARR Strength, Shares Jump

Simulations Plus, ilaç geliştirmede Nvidia ile ortaklık kurdu

Simulations Plus hisseleri NVIDIA iş birliğiyle %28 yükseldi

Do Options Traders Know Something About Simulations Plus Stock We Don't?

Cadence Q1 Earnings Top Estimates, 2026 Revenue Outlook Raised

Iridium's Q1 Earnings Miss Estimates, Revenues Increase Y/Y

SAP's Q1 Earnings & Revenues Up Y/Y on Cloud Momentum & AI Tailwinds

Simulations Plus, Lonza ve FDA ile ilaç formülasyonu araştırması

Badger Meter's Q1 Earnings & Revenues Miss Estimates, Stock Dips

Simulations Plus: Down Substantially, Not An Automatic Buy (NASDAQ:SLP)

Simulations Plus Q2 Earnings & Revenues Beat, Jump Y/Y, Shares Soar

TD Cowen, vergi endişeleri nedeniyle Simulations Plus hedefini düşürdü